Xanomeline in mild and moderate Alzheimer's disease; the effects of a novel M1 agonist on behavior

By Bodick N.C.   Offen W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 254-255

Elsevier

Access to resources Recommend Favorite

Efficacy and Safety of Valsartan/Hydrochlorothiazide Fixed-dose Combination Compared with Amlodipine Monotherapy as First-line Therapy for Mild to Moderate Hypertension

By Chao CL   Lin YH   Lin LC   Lin LY   Tsai CT   Wang YC   Hwang JJ   Chen JC   Chiang FT  

The Journal of International Medical Research, Vol. 37, Iss. 2, 2009-03 ,pp. : 289-297

Field House Publishing

Access to resources Recommend Favorite

Rivastigmine Transdermal Patch Skin Tolerability: Results of a 1-Year Clinical Trial in Patients with Mild-to-Moderate Alzheimer's Disease

By Cummings Jeffrey L.  

Clinical Drug Investigation, Vol. 30, Iss. 1, 2010-01 ,pp. : 41-49

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Olmesartan in the Treatment of Mild-to-Moderate Essential Hypertension in Chinese Patients

By Liau Chiau-Suong  

Clinical Drug Investigation, Vol. 25, Iss. 7, 2005-01 ,pp. : 473-479

Adis International

Access to resources Recommend Favorite

Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan

By Nakamura Yu   Kitamura Shin   Homma Akira   Shiosakai Kazuhito   Matsui Daiju  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 913-925

Informa Healthcare

Access to resources Recommend Favorite